From the publishers of JADPRO

Graft-vs.-Host Disease Resource Center

Advertisement

Prevention of acute GVHD disease using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T-cells in vivo

Last Updated: Tuesday, January 3, 2023

A new study shows a potential approach for enhancing the efficacy of regulatory T cell therapy after alloHCT using an oIL2/oIL2Rβ system. Regulatory T cell therapies have shown to be effective in efficacious in treating GVHD.

Blood
Advertisement
News & Literature Highlights
Advertisement
Advertisement